Drugplain

Vicks VapoCool SEVERE plus Intense Pain Relief 15 mg/1

Benzocaine and Menthol · LOZENGE · The Procter & Gamble Manufacturing Company

No Recall History
Plain English

Vicks VapoCool SEVERE plus Intense Pain Relief is a lozenge containing benzocaine and menthol at 15 mg/1, taken oral. Manufactured by The Procter & Gamble Manufacturing Company.

Key Facts

Brand Name
Vicks VapoCool SEVERE plus Intense Pain Relief
Generic Name
Benzocaine and Menthol
NDC Code (Product)
84126-366
Manufacturer
The Procter & Gamble Manufacturing Company
Strength
15 mg/1
Dosage Form
LOZENGE
Route
ORAL
Marketing Status
Application #
M022
Drug Class
Standardized Chemical Allergen [EPC]
Marketing Start
07/15/2025

Recall History

No Recall History

Frequently Asked Questions

What is Vicks VapoCool SEVERE plus Intense Pain Relief used for?

Vicks VapoCool SEVERE plus Intense Pain Relief contains Benzocaine and Menthol. It is a lozenge taken oral. Consult your doctor for specific uses.

Is Vicks VapoCool SEVERE plus Intense Pain Relief a controlled substance?

Vicks VapoCool SEVERE plus Intense Pain Relief is not classified as a controlled substance by the DEA.

What is the generic name for Vicks VapoCool SEVERE plus Intense Pain Relief?

The generic name for Vicks VapoCool SEVERE plus Intense Pain Relief is Benzocaine and Menthol. There are 11 other brand versions of Benzocaine and Menthol.

What is the NDC code for Vicks VapoCool SEVERE plus Intense Pain Relief 15 mg/1?

The NDC (National Drug Code) for Vicks VapoCool SEVERE plus Intense Pain Relief 15 mg/1 is 84126-366, listed by The Procter & Gamble Manufacturing Company.